Evaluation of choroidal thickness in prodromal Alzheimer's disease defined by amyloid PET.

Evaluation of choroidal thickness in prodromal Alzheimer's disease defined by amyloid PET.

<h4>Objective</h4>To assess and compare the involvement of choroidal thickness (CT) in patients with mild cognitive impairment (MCI) and dementia due to Alzheimer's disease (AD) defined by amyloid PET and healthy controls (HC).<h4>Methods</h4>Sixty-three eyes from 34 AD...

Full description

Bibliographic Details
Main Authors:	Alicia López-de-Eguileta, Carmen Lage, Sara López-García, Ana Pozueta, María García-Martínez, Martha Kazimierczak, María Bravo, María de Arcocha-Torres, Ignacio Banzo, Julio Jimenez-Bonilla, Andrea Cerveró, Alexander Goikoetxea, Eloy Rodríguez-Rodríguez, Pascual Sánchez-Juan, Alfonso Casado
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0239484

Similar Items

The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals
by: Alicia López-de-Eguileta, et al.
Published: (2022-04-01)

Sleep Time Estimated by an Actigraphy Watch Correlates With CSF Tau in Cognitively Unimpaired Elders: The Modulatory Role of APOE
by: Sara López-García, et al.
Published: (2021-08-01)

The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer
by: Julio Francisco Jiménez-Bonilla, et al.
Published: (2016-09-01)

Ganglion Cell Layer Thinning in Alzheimer’s Disease
by: Alicia López-de-Eguileta, et al.
Published: (2020-10-01)

Retinal Artery Contraction After Phenylephrine as a Cardiovascular Risk Biomarker
by: Casado A, et al.
Published: (2020-05-01)

FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
by: Kejal Kantarci, et al.
Published: (2021-01-01)

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis
by: Gregory Klein, et al.
Published: (2019-12-01)

APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease.
by: Timothy J Hohman, et al.
Published: (2017-01-01)

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
by: Sonia Monge-García, et al.
Published: (2023-05-01)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
by: Ming-Chyi Pai, et al.
Published: (2021-10-01)

Outer Nuclear Layer Damage for Detection of Early Retinal Toxicity of Hydroxychloroquine
by: Alfonso Casado, et al.
Published: (2020-03-01)

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform
by: Francisco Martínez-Dubarbie, et al.
Published: (2023-10-01)

Polypoidal choroidopathy associated with choroidal nevus
by: Isabel Pascual-Camps, et al.
Published: (2017-01-01)

Assessment of Amyloid Deposition in Patients With Probable REM Sleep Behavior Disorder as a Prodromal Symptom of Dementia With Lewy Bodies Using PiB-PET
by: Ryota Kobayashi, et al.
Published: (2019-06-01)

sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer’s disease: The CABLE study
by: Zhi-Bo Wang, et al.
Published: (2022-04-01)

Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer's Disease Independent of Amyloid-β Production and Tau Phosphorylation
by: Fátima Mesa-Herrera, et al.
Published: (2022-05-01)

Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
by: Javier Mar, et al.
Published: (2020-12-01)

Editorial: Prodromal Parkinson's Disease
by: David Crosiers, et al.
Published: (2021-01-01)

Influence of Physiological Variables and Comorbidities on Plasma Aβ40, Aβ42, and p-tau181 Levels in Cognitively Unimpaired Individuals
by: Francisco Martínez-Dubarbie, et al.
Published: (2024-01-01)

THE LOCUS COERULEUS-HIPPOCAMPUS AXIS IN PRODROMAL PHASES OF PARKINSON’S DISEASE.
by: Laura De Las Heras-García, et al.
Published: (2023-10-01)

Prodromal dementia with Lewy bodies: a case series of the 3 prodromal types from clinical practice
by: Tracy Tholanikunnel, et al.
Published: (2023-08-01)

Philosophical issues in the prodromal phase of psychosis.
by: Broome, M, et al.
Published: (2012)

Signaling prodromes of sudden cardiac death
by: Ivana I. Vranic
Published: (2013-02-01)

Gastrointestinal conditions in the multiple sclerosis prodrome
by: Fardowsa L. A. Yusuf, et al.
Published: (2024-01-01)

Prodromal stage of late-onset psychosis
by: V. Pochueva, et al.
Published: (2022-06-01)

Phenotype fingerprinting of bipolar disorder prodrome
by: Yijun Shao, et al.
Published: (2023-05-01)

Animal Models of Relevance to the Schizophrenia Prodrome
by: Alice Petty, et al.
Published: (2023-01-01)

Genealogy of instruments for prodrome evaluation of psychosis
by: Jean-Gabriel eDaneault, et al.
Published: (2013-04-01)

Motor Symptoms as a Prodrome to Schizophrenia
by: Adam Schindzielorz, et al.
Published: (2022-01-01)

Applicability of the Chinese Version of the Prodromal Questionnaire
by: Shu-Chen Chiu, et al.
Published: (2010-09-01)

Study of prodromal and residual symptoms of depression
by: Vishal B Pede, et al.
Published: (2017-01-01)

Prodromal Alzheimer’s Disease: Constitutive Upregulation of Neuroglobin Prevents the Initiation of Alzheimer’s Pathology
by: Silvia de Vidania, et al.
Published: (2020-12-01)

Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson’s Disease
by: Óscar Peña-Nogales, et al.
Published: (2019-01-01)

Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
by: Magda Gharbiya, et al.
Published: (2023-01-01)

Topographic correlation and asymmetry analysis of ganglion cell layer thinning and the retinal nerve fiber layer with localized visual field defects.
by: Alfonso Casado, et al.
Published: (2019-01-01)

Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease
by: Evelien De Groote, et al.
Published: (2020-07-01)

AMYLOID-BETA SCAVENGERS’ EXPRESSION IN THE CHOROID PLEXUS IS AGE-, SEX-, AND CIRCADIAN-DEPENDENT
by: Ana Catarina Duarte, et al.
Published: (2023-10-01)

Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease
by: Caterina Visconte, et al.
Published: (2023-09-01)

MS Prodrome; Is it a fact? (ORP-02)
by: Farhad Golipoor
Published: (2023-11-01)

Sex and age differences in the Multiple Sclerosis prodrome
by: Fardowsa L. A. Yusuf, et al.
Published: (2022-11-01)